Bruce Kramer participated in a drug trial to determine if Dexpramipexole could slow the progression of ALS.
Kramer felt the drug was working for him and was frustrated when the trial was terminated.
Your support matters.
You make MPR News possible. Individual donations are behind the clarity in coverage from our reporters across the state, stories that connect us, and conversations that provide perspectives. Help ensure MPR remains a resource that brings Minnesotans together.